We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Barr Sued Over Plan For Schizophrenia Drug

Law360 (March 21, 2007, 12:00 AM EDT) -- Japanese drug maker Otsuka Pharmaceutical Co. Ltd. has filed a patent infringement lawsuit against Barr Pharmaceuticals Inc. over its plan to manufacture a generic version of Otsuka’s schizophrenia drug, Abilify.

Otsuka filed the lawsuit in response to Barr’s abbreviated new drug application, filed in November with the U.S. Food and Drug Administration. The ANDA, which seeks permission to make the generic version, claims Otsuka’s patent for Abilify is invalid.

The lawsuit was filed on March 16 with the U.S. District Court for the District of New...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.